2110 Pharmacy prior authorization  

  • DEPARTMENT OF
    HUMAN SERVICES

    Pharmacy Prior Authorization

    [45 Pa.B. 6860]
    [Saturday, November 28, 2015]

     The Department of Human Services (Department) announces it will add Alpha 1-Proteinase Inhibitors, Corlanor and Orkambi to the Medical Assistance (MA) Program's list of services and items requiring prior authorization.

     Section 443.6(b)(7) of the Public Welfare Code (62 P. S. § 443.6(b)(7)) authorizes the Department to add items and services to the list of services requiring prior authorization by publication of notice in the Pennsylvania Bulletin.

     The MA Program will require prior authorization of all prescriptions for Alpha 1-Proteinase Inhibitors, Corlanor and Orkambi. These prior authorization requirements apply to prescriptions dispensed on or after December 1, 2015.

     The Department will issue MA Bulletins to providers enrolled in the MA Program specifying the procedures for obtaining prior authorization of prescriptions for each of the medications previously listed.

    Fiscal Impact

     These changes are estimated to result in savings totaling $0.074 million ($0.035 million in State funds) in the MA Outpatient Program in Fiscal Year (FY) 2015-2016. Savings are estimated $0.177 million ($0.085 million in State funds) in FY 2016-2017.

    Public Comment

     Interested persons are invited to submit written comments regarding this notice to the Department of Human Services, Office of Medical Assistance Programs, c/o Regulations Coordinator, Room 515, Health and Welfare Building, Harrisburg, PA 17120. Comments received within 30 days will be reviewed and considered for any subsequent revisions to these prior authorization requirements.

     Persons with a disability who require an auxiliary aid or service may submit comments using the Pennsylvania AT&T Relay Service at (800) 654-5984 (TDD users) or (800) 654-5988 (voice users).

    THEODORE DALLAS, 
    Secretary

    Fiscal Note: 14-NOT-982. (1) General Fund; (2) Implementing Year 2015-16 is -$35,000; (3) 1st Succeeding Year 2016-17 through 5th Succeeding Year 2020-21 are -$85,000; (4) 2014-15 Program—$348,741,000; 2013-14 Program—$264,179,000; 2012-13 Program—$450,835,000; (7) MA—Outpatient; (8) recommends adoption. This action will result in savings to the Commonwealth.

    [Pa.B. Doc. No. 15-2110. Filed for public inspection November 25, 2015, 9:00 a.m.]

Document Information